Arrhythmias & electrophysiology
Hybrid atrial fibrillation ablation: long-term outcomes from a single-centre 10-year experience
Authors' conclusion
In a large cohort of patients undergoing hybrid AF ablation, the survival from ATas recurrence was 47.5% at ≈5 years follow-up. There was no difference in clinical outcomes between patients undergoing hybrid AF ablation as first procedure or as a redo.
Study context
- Population
- Consecutive patients undergoing one-step hybrid atrial fibrillation (AF) ablation (thoracoscopic ablation then endocardial mapping/ablation; all PVI and posterior wall isolation), UZ Brussel, 2010–2020
- Participants
- 120 patients
- Exposure
- Hybrid AF ablation as first procedure vs as redo procedure
- First proceduren = 85
- Second proceduren = 20
- Third proceduren = 15
- Outcome
- Freedom from atrial tachyarrhythmias (ATas)
- Follow-up
- Mean 62.3 months ± 20.3
Methodological detailssingle-centre, consecutive patients
- Single-centre
- Consecutive patients
Main finding
As reported in the abstract
ATas recurrence
Patients with atrial tachyarrhythmias (ATas) recurrence
63
52.5%
Survival from ATas recurrence at ≈5 years
47.5%
Observational data: associations, not effects.
Further findings
Predictors of ATas recurrence
- Left atrial volume index and recurrence during blanking period were independent predictors
Safety
- Patients with complications
- 12.5%
Original publication
Hybrid atrial fibrillation ablation: long-term outcomes from a single-centre 10-year experience. Europace. Published 29 May 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →